Showing results (121-130 of 258) with videos related to
Sort By:
Pageof 26
Bone|August 29, 2006
The circadian rhythm of biochemical markers of bone resorption is normally synchronized in breast cancer patients with bone lytic metastases independently of tumor loadDaniele Generali, Alfredo Berruti, Marco Tampellini, et al.Cancer Immunology, Immunotherapy : CII|December 18, 2025
Immune biomarkers for head and neck cancerNavid Sobhani, Alberto D'Angelo, Fernanda G Kugeratski, et al.Pharmaceuticals (Basel, Switzerland)|March 6, 2021
Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of LiteratureOttavia Bernocchi, Marianna Sirico, Silvia Paola Corona, et al.Expert Review of Gastroenterology & Hepatology|July 5, 2016
Apatinib for the treatment of gastric cancerGiandomenico Roviello, Andrea Ravelli, Anna Ida Fiaschi, et al.Future Oncology (London, England)|February 13, 2015
Eribulin in heavily pretreated metastatic breast cancer patients and clinical/biological feature correlations: impact on the practiceAlessandra Fabi, Luca Moscetti, Mariangela Ciccarese, et al.Plos One|July 5, 2013
Triple negative breast cancers have a reduced expression of DNA repair genesEnilze Ribeiro, Monica Ganzinelli, Daniele Andreis, et al.British Journal of Cancer|November 28, 2018
Early immune modulation by single-agent trastuzumab as a marker of trastuzumab benefitTiziana Triulzi, Viola Regondi, Loris De Cecco, et al.Expert Review of Anticancer Therapy|May 1, 2015
Immune-related strategies driving immunotherapy in breast cancer treatment: a real clinical opportunityAndrea Ravelli, James M Reuben, Francesco Lanza, et al.Medical Oncology (Northwood, London, England)|July 31, 2015
Ibrutinib: from bench side to clinical implicationsDavide Grisafi, Alessandra Maestro, Camilla Grumi, et al.Oncotarget|June 25, 2020
Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET studySilvia P Corona, Fabiola Giudici, Guy Jerusalem, et al.Pageof 26